Myomo Inc. Insider Trading

MYO

Last 12 months

Insiders bought 443K and sold 181K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Commercial Officer Micah Mitchell sold 78K on May 14, 45% of their stake, outside a plan.

Net open-market

+261K

9 buys · 5 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

4 / 3

executives and directors

Last open-market buy

Jun 2026

Jun 5, 2026

Get an email when MYO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 11	Harry Kovelman Chief Medical Officer	SoldNo plan	15,844	$1.27	20K	15%	Form 4
Sep 2	Milton Mayo Morris Director	SoldNo plan	15,000	$1.41	21K	6.7%	Form 4
Aug 20	Harry Kovelman Chief Medical Officer	SoldNo plan	17,500	$1.73	30K	14%	Form 4
Jun 5	Thomas F Kirk Director	Bought	40,002	$1.27	51K	6.1%	Form 4
May 28	Thomas F Kirk Director	Bought	25,000	$0.99	25K	4.0%	Form 4
May 27 – 28	Harry Kovelman Chief Medical Officer	SoldNo plan 2 parts	32,000	$1.01 average	32K	23%	Form 4
May 15 – 18	Thomas F Kirk Director	Bought 2 parts	75,006	$0.91 average	68K	14%	Form 4
May 14 – 15	Joseph M. Manko Jr. Director	Bought 2 parts	201,197	$0.86 average	174K	9.5%	Form 4
May 14	Micah Mitchell Chief Commercial Officer	SoldNo plan	90,231	$0.86	78K	45%	Form 4
Mar 16	Heather C Getz Director	Bought	20,000	$0.70	14K	18%	Form 4
Mar 13	Thomas F Kirk Director	Bought	72,000	$0.71	51K	15%	Form 4
Mar 12	Heather C Getz Director	Bought	70,000	$0.73	51K	168%	Form 4
Nov 20, 2025 – Nov 21, 2025	Thomas F Kirk Director	Bought 2 parts	7,437	$0.72 average	5K	1.6%	Form 4
Nov 18, 2025 – Nov 19, 2025	Thomas Aloysius Crowley Jr. Director	Bought 2 parts	4,385	$0.73 average	3K	6.1%	Form 4
Aug 25, 2025	Thomas F Kirk Director	Bought	50,000	$1.15	58K	12%	Form 4
Aug 18, 2025	Thomas F Kirk Director	Bought	50,000	$1.10	55K	13%	Form 4
Aug 15, 2025	Paul R Gudonis Chief Executive Officer	Bought	50,000	$0.95	48K	4.1%	Form 4
May 14, 2025 – May 15, 2025	Thomas F Kirk Director	Bought 2 parts	38,767	$3.25 average	126K	13%	Form 4
May 15, 2025	Paul R Gudonis Chief Executive Officer	Bought	30,000	$3.22	97K	2.9%	Form 4
May 14, 2025	Micah Mitchell Chief Commercial Officer	SoldNo plan	90,231	$0.86	78K	45%	Form 4
May 12, 2025	Thomas F Kirk Director	Bought	50,000	$3.35	168K	20%	Form 4
Mar 14, 2025	Micah Mitchell Chief Commercial Officer	SoldNo plan	48,000	$5.16	248K	25%	Form 4
Mar 14, 2025	Micah Mitchell Chief Commercial Officer	SoldNo plan	48,000	$5.16	248K	25%	Form 4
Mar 13, 2025	Thomas F Kirk Director	Bought	7,400	$5.00	37K	3.0%	Form 4
Mar 12, 2025	Harry Kovelman Chief Medical Officer	SoldNo plan	30,000	$5.50	165K	24%	Form 4

Sep 11No plan
Harry Kovelman
Chief Medical Officer · sold 15,844 at $1.27
20K
15% of stake
Sep 2No plan
Milton Mayo Morris
Director · sold 15,000 at $1.41
21K
6.7% of stake
Aug 20No plan
Harry Kovelman
Chief Medical Officer · sold 17,500 at $1.73
30K
14% of stake
Jun 5
Thomas F Kirk
Director · bought 40,002 at $1.27
51K
6.1% of stake
May 28
Thomas F Kirk
Director · bought 25,000 at $0.99
25K
4.0% of stake
May 27 – 28No plan
Harry Kovelman
Chief Medical Officer · sold 32,000 at avg $1.01
32K
23% of stake
May 15 – 18
Thomas F Kirk
Director · bought 75,006 at avg $0.91
68K
14% of stake
May 14 – 15
Joseph M. Manko Jr.
Director · bought 201,197 at avg $0.86
174K
9.5% of stake
May 14No plan
Micah Mitchell
Chief Commercial Officer · sold 90,231 at $0.86
78K
45% of stake
Mar 16
Heather C Getz
Director · bought 20,000 at $0.70
14K
18% of stake
Mar 13
Thomas F Kirk
Director · bought 72,000 at $0.71
51K
15% of stake
Mar 12
Heather C Getz
Director · bought 70,000 at $0.73
51K
168% of stake
Nov 20, 2025 – Nov 21, 2025
Thomas F Kirk
Director · bought 7,437 at avg $0.72
5K
1.6% of stake
Nov 18, 2025 – Nov 19, 2025
Thomas Aloysius Crowley Jr.
Director · bought 4,385 at avg $0.73
3K
6.1% of stake
Aug 25, 2025
Thomas F Kirk
Director · bought 50,000 at $1.15
58K
12% of stake
Aug 18, 2025
Thomas F Kirk
Director · bought 50,000 at $1.10
55K
13% of stake
Aug 15, 2025
Paul R Gudonis
Chief Executive Officer · bought 50,000 at $0.95
48K
4.1% of stake
May 14, 2025 – May 15, 2025
Thomas F Kirk
Director · bought 38,767 at avg $3.25
126K
13% of stake
May 15, 2025
Paul R Gudonis
Chief Executive Officer · bought 30,000 at $3.22
97K
2.9% of stake
May 14, 2025No plan
Micah Mitchell
Chief Commercial Officer · sold 90,231 at $0.86
78K
45% of stake
May 12, 2025
Thomas F Kirk
Director · bought 50,000 at $3.35
168K
20% of stake
Mar 14, 2025No plan
Micah Mitchell
Chief Commercial Officer · sold 48,000 at $5.16
248K
25% of stake
Mar 14, 2025No plan
Micah Mitchell
Chief Commercial Officer · sold 48,000 at $5.16
248K
25% of stake
Mar 13, 2025
Thomas F Kirk
Director · bought 7,400 at $5.00
37K
3.0% of stake
Mar 12, 2025No plan
Harry Kovelman
Chief Medical Officer · sold 30,000 at $5.50
165K
24% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MYO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with MYO

CompareIntrinsic value

APTAlpha Pro Tech Ltd.

$5.74+3.24%61

LFWDLifeward Ltd.

$6.06+3.95%40

LGMKLogicMark, Inc.

No recent price35

MLSSMilestone Scientific Inc.

$0.33+10.00%25

SMTISanara MedTech Inc.

$32.33+0.50%51

LAKELakeland Industries Inc.

$8.93-0.11%15

ESTAEstablishment Labs Holdings Inc.

$66.94+9.02%30

INGNInogen Inc.

$7.22+2.85%25

Spot a number that looks wrong? Check it in MYO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MYO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.